It is a pharma private limited company based in Kozhikode, Kerala, India, established in 2019.
2019 | Kozhikode, Kerala, India | ActiveGlorritus Pharmaceuticals Private Limited, a active private limited company, was established on 02 January 2019 in Kozhikode, Kerala, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U33209KL2019PTC056158. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Manoharan Ajith (Director), Pulikkal Beljith (Managing Director), Valiya Parambil Sunilkumar (Director). It holds ₹4.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 65/3930,Jaya Building, Wayanad Road,East Nadakkavu, Kozhikode, Kerala, 673006.
U33209KL2019PTC056158
056158
02 January 2019
₹1.00 M
₹0.10 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Glorritus Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manoharan Ajith | Director | 10 Jan 2020 | Current |
| Pulikkal Beljith | Managing Director | 10 Jan 2020 | Current |
| Valiya Parambil Sunilkumar | Director | 02 Jan 2019 | Current |
| Kuyil Veedu Chandran | Director | 02 Jan 2019 | Current |
| Manilal Chandran Manaikudath | Director | 10 Jan 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Glorritus Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 16.08% decrease. The company also saw a substantial improvement in profitability, with a 121.06% increase in profit. The company's net worth Soared by an impressive increase of 26.43%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Glorritus Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Mar 2025 | Others | ₹4.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Glorritus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Glorritus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glorritus Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Glorritus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Glorritus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam. was completed.
A charge with Others amounted to Rs. 4.00 M with Charge ID 101084917 was registered on 26 Mar 2025. was recorded as a recent event.
Progress on Manoharan Ajith was appointed as a Director was appointed as a Director on 10 Jan 2020 & has been associated with this company since 5 years 11 months . was documented.
Pulikkal Beljith was appointed as a Managing Director was appointed as a Managing Director on 10 Jan 2020 & has been associated with this company since 5 years 11 months . was recorded as a recent event.
Progress on Manilal Chandran Manaikudath was appointed as a Director was appointed as a Director on 10 Jan 2020 & has been associated with this company since 5 years 11 months . was documented.
The CIN of Glorritus Pharmaceuticals Private Limited is U33209KL2019PTC056158.
Glorritus Pharmaceuticals Private Limited is headquartered at 65/3930,Jaya Building, Wayanad Road,East Nadakkavu, Kozhikode, Kerala, 673006.
Glorritus Pharmaceuticals Private Limited was incorporated on 02 January 2019.
The current directors of Glorritus Pharmaceuticals Private Limited are
The primary industry of Glorritus Pharmaceuticals Private Limited is Manufacturing.
Glorritus Pharmaceuticals Private Limited is unlisted.
The authorized capital of Glorritus Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX